Regional Eligibility Screening Nearly Doubles Cancer Clinical Trial Opportunities, May Increase Enrollment, New Papers Show
New findings led by researchers at the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) show that regional trial eligibility screening holds the promise of substantially increasing the number of patients who are found eligible to enroll in cancer clinical trials.